Baseline characteristics and final diagnoses
| VBNA group (n=102) | NVBNA group (n=97) | |
| Age (years, median; range) | 69 (21–85) | 67 (27–82) |
| Male, n (%) | 64 (62.7) | 57 (58.8) |
| Lesion size (mm, median; range) | 18.0 (9.5–30.0) | 18.0 (7.0–30.0) |
| <20 mm, n (%) | 59 (57.8) | 59 (60.8) |
| 20–30 mm, n (%) | 43 (42.2) | 38 (39.2) |
| Lesion location | ||
| Rt. upper lobe, n (%) | 32 (31.4) | 35 (36.1) |
| Rt. middle lobe, n (%) | 12 (11.8) | 6 (6.2) |
| Rt. lower lobe, n (%) | 23 (22.5) | 18 (18.6) |
| Lt. upper lobe, n (%) | 25 (24.5) | 21 (21.6) |
| Lt. lower lobe, n (%) | 10 (9.8) | 17 (17.5) |
| Final diagnosis | ||
| Malignant disease n (%) | ||
| Primary lung cancer n (%) | 69 (67.6) | 76 (78.4) |
| Other malignant disease n (%) | 10 (9.8) | 4 (4.1) |
| Non-malignant disease n (%) | ||
| Infectious disease n (%) | 17 (16.7) | 8 (8.2) |
| Other benign condition n (%) | 5 (4.9) | 9 (9.3) |
| Undetermined n (%) | 1 (1.0) | 0 (0) |
Lt., left; NVBNA, non-virtual bronchoscopic navigation-assisted; Rt., right; VBNA, virtual bronchoscopic navigation-assisted.